Sigyn Therapeutics
Sigyn Therapeutics is a Healthcare & Life Sciences startup based in Ireland, most recent round Series A, 2 tracked investors.
About Sigyn Therapeutics
Based in Ireland, Sigyn Therapeutics is a startup. Its most recent tracked round is Series A. Brouky classifies it under Healthcare & Life Sciences. Brouky records 2 investors associated with the company.
Sigyn Therapeutics develops CardioDialysis™, a medical device designed to reduce circulating inflammatory molecules and cholesterol-transporting lipoproteins to lower the risk of major adverse cardiovascular events. The device leverages existing dialysis infrastructure for potential broad-scale deployment in U.S. dialysis clinics.
Explore Sigyn Therapeutics's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.